ImportantCompany Update
The company has allotted 7,53,334 new equity shares to a non-promoter warrant holder upon conversion.
Venmax Drugs and Pharmaceuticals Ltd531015 · Filed with the exchange
These shares were issued at Rs. 20 each, bringing in an additional 1.13 Cr as the balance exercise price.
This boosts the company's paid-up capital to 14.48 Cr, now comprising 1.45 Cr shares.
Investors should note 7.80 lakh warrants are still pending conversion, signaling potential future equity expansion.
No comments yet. Be the first.